Cargando…
Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation
Hematopoietic chimerism after allogeneic bone marrow transplantation may establish a state of donor antigen-specific tolerance. However, current allotransplantation protocols involve genotoxic conditioning which has harmful side-effects and predisposes to infection and cancer. Here we describe a non...
Autores principales: | Li, Zhanzhuo, Czechowicz, Agnieszka, Scheck, Amelia, Rossi, Derrick J., Murphy, Philip M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365540/ https://www.ncbi.nlm.nih.gov/pubmed/30728353 http://dx.doi.org/10.1038/s41467-018-08202-w |
Ejemplares similares
-
The Macrophage-depleting Agent Clodronate Promotes Durable Hematopoietic Chimerism and Donor-specific Skin Allograft Tolerance in Mice
por: Li, Zhanzhuo, et al.
Publicado: (2016) -
Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation
por: Czechowicz, Agnieszka, et al.
Publicado: (2019) -
Tolerance of a Vascularized Composite Allograft Achieved in MHC Class-I-mismatch Swine via Mixed Chimerism
por: Lellouch, Alexandre G., et al.
Publicado: (2022) -
MHC Mismatch Inhibits Neurogenesis and Neuron Maturation in Stem Cell Allografts
por: Chen, Zhiguo, et al.
Publicado: (2011) -
A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal Allotransplantation
por: Sommer, Wiebke, et al.
Publicado: (2021)